{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:30:28Z","timestamp":1790227828876,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"DOI":"10.1007\/s00270-025-04158-9","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T19:52:17Z","timestamp":1755201137000},"page":"1355-1360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Glue Penetration Index Score for Use during Glue Prostate Artery Embolization"],"prefix":"10.1007","volume":"48","author":[{"given":"Conrad","family":"von Stempel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Vigneswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Quirantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Nowfal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shian","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beckett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romaric","family":"Loffroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5190-2694","authenticated-orcid":false,"given":"Clare","family":"Bent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"4158_CR1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2016152292","author":"T Bilhim","year":"2016","unstructured":"Bilhim T, et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology. 2016. https:\/\/doi.org\/10.1148\/radiol.2016152292.","journal-title":"Radiology"},{"key":"4158_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-023-03367-4","author":"G Vigneswaran","year":"2023","unstructured":"Vigneswaran G, et al. Mid-term results of the prospective LUMI-PAE study: propensity-matched analysis of 1-year follow-up data. Cardiovasc Intervent Radiol. 2023. https:\/\/doi.org\/10.1007\/s00270-023-03367-4.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4158_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2020.02.029","author":"SZ Maron","year":"2020","unstructured":"Maron SZ, Cedillo MA, Sher A, Kim J, Fischman AM. Use of 70- to 150-\u03bcm radiopaque spherical embolics for prostatic artery embolization. J Vasc Interv Radiol. 2020. https:\/\/doi.org\/10.1016\/j.jvir.2020.02.029.","journal-title":"J Vasc Interv Radiol"},{"key":"4158_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2022.01.014","author":"B Brown","year":"2022","unstructured":"Brown B, Yu H, Bagla S, Isaacson A. Nontarget radiopaque embolic deposition during prostatic artery embolization. J Vasc Interv Radiol. 2022. https:\/\/doi.org\/10.1016\/j.jvir.2022.01.014.","journal-title":"J Vasc Interv Radiol"},{"key":"4158_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-08063-w","author":"A Hakim\u00e9","year":"2021","unstructured":"Hakim\u00e9 A, et al. Using prostate contrast retention (PCR) as the procedural endpoint in prostatic artery embolization for benign prostatic hyperplasia. Eur Radiol. 2021. https:\/\/doi.org\/10.1007\/s00330-021-08063-w.","journal-title":"Eur Radiol"},{"key":"4158_CR6","doi-asserted-by":"publisher","DOI":"10.5152\/dir.2019.18410","author":"H Moschouris","year":"2019","unstructured":"Moschouris H, et al. The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia. Diagn Interv Radiol. 2019. https:\/\/doi.org\/10.5152\/dir.2019.18410.","journal-title":"Diagn Interv Radiol"},{"key":"4158_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2023.12.006","author":"R Loffroy","year":"2024","unstructured":"Loffroy R, et al. Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: a six-month outcome analysis in 103 patients. Diagn Interv Imaging. 2024. https:\/\/doi.org\/10.1016\/j.diii.2023.12.006.","journal-title":"Diagn Interv Imaging"},{"key":"4158_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-022-03069-3","author":"E Salet","year":"2022","unstructured":"Salet E, et al. Prostatic artery embolization for benign prostatic obstruction: single-centre retrospective study comparing microspheres versus n-butyl cyanoacrylate. Cardiovasc Intervent Radiol. 2022. https:\/\/doi.org\/10.1007\/s00270-022-03069-3.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4158_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-017-1703-4","author":"DK Filippiadis","year":"2017","unstructured":"Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the Cirse classification system. Cardiovasc Intervent Radiol. 2017. https:\/\/doi.org\/10.1007\/s00270-017-1703-4.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4158_CR10","doi-asserted-by":"crossref","unstructured":"Altman DG, Practical statistics for medical research. 1990.","DOI":"10.1201\/9780429258589"},{"key":"4158_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-008-1277-2","author":"T Baere","year":"2009","unstructured":"Baere T, Denys A, Paradis V. Comparison of four embolic materials for portal vein embolization: experimental study in pigs. Eur Radiol. 2009. https:\/\/doi.org\/10.1007\/s00330-008-1277-2.","journal-title":"Eur Radiol"},{"key":"4158_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S1051-0443(07)61568-1","author":"JS Pollak","year":"2001","unstructured":"Pollak JS, White J. The use of cyanoacrylate adhesives in peripheral embolization. J Vasc Interv Radiol. 2001. https:\/\/doi.org\/10.1016\/S1051-0443(07)61568-1.","journal-title":"J Vasc Interv Radiol"},{"key":"4158_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2020.04.027","author":"NV Costa","year":"2020","unstructured":"Costa NV, et al. Repeat prostatic artery embolization for patients with benign prostatic hyperplasia. J Vasc Interv Radiol. 2020. https:\/\/doi.org\/10.1016\/j.jvir.2020.04.027.","journal-title":"J Vasc Interv Radiol"},{"key":"4158_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-020-02671-7","author":"DJ Kearns","year":"2021","unstructured":"Kearns DJ, Boardman P, Tapping CR. Patterns of reperfusion and clinical findings in repeat prostate artery embolisation for recurrent lower urinary tract symptoms in patients with benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2021. https:\/\/doi.org\/10.1007\/s00270-020-02671-7.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"4158_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-015-1267-0","author":"G Amouyal","year":"2016","unstructured":"Amouyal G, et al. Clinical results after prostatic artery embolization using the PErFecTED technique: a single-center study. Cardiovasc Intervent Radiol. 2016. https:\/\/doi.org\/10.1007\/s00270-015-1267-0.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"4158_CR16","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s00270-014-0908-z","volume":"37","author":"FC Carnevale","year":"2014","unstructured":"Carnevale FC, Moreira AM, Antunes AA. The \u2018PErFecTED Technique\u2019: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Intervent Radiol. 2014;37(6):1602\u20135. https:\/\/doi.org\/10.1007\/s00270-014-0908-z.","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-04158-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-025-04158-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-025-04158-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:00:17Z","timestamp":1758816017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-025-04158-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":16,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["4158"],"URL":"https:\/\/doi.org\/10.1007\/s00270-025-04158-9","relation":{},"ISSN":["1432-086X"],"issn-type":[{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CB (Author 1) has received a research grant and a speaker honorarium from Guerbet and a speaker honorarium from Merit Medical. ML (Author 5) is a paid consultant for Merit Medical, Crannmed, Boston Scientific, Varian and Guerbet; has received support to attend meetings from Merit Medical and Guerbet; and has received research grants from Merit Medical and Varian. The remaining authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Ethics approval was granted by local ethics committees for each center participating in the study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"This study has obtained IRB approval from University Hospitals Dorset, and the need for informed consent was waived. Consent for publication was not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}